8-K: H.B. Fuller Reports Strong Q3 2026 Results

H.B. Fuller announced robust third quarter 2026 financial results, showcasing significant year-over-year growth in net revenue, adjusted EBITDA, and earnings per share, alongside margin expansion.

Summary

• H.B. Fuller reported third quarter 2026 net revenue of $938 million, a 5.2% increase year-over-year, with organic revenue up 4.4%.
• The company achieved a net income of $79 million and adjusted EBITDA of $187 million, marking a 9% increase year-over-year.
• Adjusted EBITDA margin reached a record 19.9%, up 80 basis points from the prior year.
• Reported diluted EPS was $1.44, while adjusted diluted EPS rose 21% year-over-year to $1.52.
• Gross margin improved to 33.2%, with adjusted gross margin at 33.5%, up 120 basis points, driven by pricing and restructuring savings.
• Year-to-date cash flow from operations was $183 million, up 17% year-over-year.
• The company updated its fiscal 2026 outlook, expecting net revenue to be up mid-single digits and adjusted EBITDA in the range of $655 million to $670 million.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong revenue and earnings growth, improved margins, and an optimistic outlook, indicating solid operational performance and strategic execution.

Positives

• Net revenue increased by 5.2% to $938 million, with organic revenue growth of 4.4% across all global business units.
• Adjusted EBITDA grew by 9% to $187 million, with a record adjusted EBITDA margin of 19.9%, up 80 basis points.
• Adjusted diluted EPS increased by 21% year-over-year to $1.52.
• Gross margin improved by 120 basis points to 33.5% (adjusted), driven by effective pricing and restructuring savings.
• Year-to-date cash flow from operations increased by 17% to $183 million.
• Net debt-to-adjusted EBITDA ratio improved to 3.0X from 3.3X in the prior year.
• All three global business units showed organic revenue growth and improved adjusted EBITDA margins.

Negatives

• Lower volume partially offset pricing gains, resulting in a 3.0% decrease in volume for the quarter.
• Net working capital as a percentage of annualized revenue increased to 18.5% from 17.0% in the prior year, due to strategic inventory investments.

Risks

• Availability and pricing of raw materials.
• Impact of potential cybersecurity attacks and security breaches.
• Failures in information technology systems.
• Supply chain disruptions and raw material cost volatility due to geopolitical events.
• Inflationary pressures impacting margins and product demand.
• Debt covenants that may limit management discretion.
• Uncertain political and economic conditions.
• Fluctuations in product demand and competing products and pricing.

Future Outlook

For fiscal year 2026, H.B. Fuller expects net revenue to be up mid-single digits and organic revenue up low-single digits. Pricing is expected to be up mid-single digits, with volume down low-single digits. Foreign exchange impact is now projected to be approximately 2%. Adjusted EBITDA is forecasted to be between $655 million and $670 million. The core tax rate is expected to be between 25.5% and 26.0%. Adjusted diluted EPS is projected to be in the range of $4.70 to $4.85. Cash flow from operations (excluding AMS-related items) is expected to be between $300 million and $325 million.

Management Comments

• "Through disciplined execution, we delivered strong revenue, EBITDA, and EPS growth in the quarter and continued to improve profitability and advance toward our EBITDA margin target of greater than 20 percent," said Celeste Mastin, president and chief executive officer.
• "Pricing actions are offsetting higher raw material costs, and our restructuring efforts continue to enhance operating leverage."
• "With the anticipated closing of the AMS acquisition before year-end, we remain focused on strengthening our portfolio, executing our Quantum Leap program, and creating long-term value for shareholders."

Industry Context

StockSavvy.ai notes that H.B. Fuller's performance, particularly its ability to drive organic growth through pricing and improve margins via restructuring, aligns with broader trends in the specialty chemicals sector where companies are navigating raw material cost volatility and supply chain challenges by focusing on value-added solutions and operational efficiency.

Comparison to Industry Standards

• H.B. Fuller's adjusted EBITDA margin of 19.9% for Q3 2026 is a record for the company and positions it favorably within the adhesives and specialty chemicals industry, where margins can vary significantly by product segment and geographic region.
• Competitors like Henkel, Arkema, and Sika also focus on pricing strategies and operational efficiencies to combat inflation and supply chain issues, though specific margin comparisons would require detailed segment-level data from those companies.
• The company's organic revenue growth of 4.4% is a solid indicator of demand for its products, especially when compared to the broader industrial manufacturing sector which can experience more cyclical fluctuations.

Legal Proceedings

• Ongoing litigation and product claims related to a divested business.

Stakeholder Impact

• Shareholders: Expected to benefit from strong EPS growth, improved profitability, and potential long-term value creation from acquisitions and strategic programs.
• Customers: May experience price increases but benefit from improved supply continuity due to strategic inventory investments.
• Employees: Restructuring efforts may impact some roles, but overall company growth and focus on value creation could lead to stability and opportunities.
• Suppliers: Increased demand from higher revenue and inventory build-up may present opportunities, but also potential pressure on pricing and supply chain coordination.

Next Steps

• Anticipated closing of the AMS acquisition before year-end.
• Continued focus on strengthening the company's portfolio.
• Execution of the Quantum Leap program.
• Creating long-term value for shareholders.

Key Dates

Recommendation

The company delivered strong Q3 results with significant growth in revenue, earnings, and margins, and has updated its full-year guidance positively. However, the increase in net working capital due to inventory build-up and ongoing risks related to raw material costs and geopolitical factors warrant a cautious approach. While the performance is encouraging, a 'hold' recommendation allows for further observation of the integration of the AMS acquisition and the sustained impact of pricing strategies against potential volume declines and broader economic uncertainties.

Keywords

adhesives, sealants, coatings, specialty chemicals, industrial manufacturing, earnings, revenue growth, EBITDA